DEXT Capital announced it has provided financing for a new Accuray Radixact Radiation Oncology Center for Integrated Oncology Network (ION) and its subsidiary, Gamma West Cancer Services. In November 2019, the Timpangos Cancer Services opened. It is the first facility in Utah to install the Radixact System, Accuray’s new and innovative radiation therapy system.

“Gammawest Cancer Services is pleased to add the Radixact 9 Tomotherapy technology to our already existing Tomotherapy platform in the State of Utah.  This linear accelerator and its associated technology will bless the lives of many patients and their families that deal with cancer,” said Dave Vincent, CEO for Gammawest Cancer Services.

“Making this powerful anti-cancer tool available to the public comes at great cost, and we would not be able to bring this technology to the market without the financing support of our excellent partner, Dext Capital.  The team at Dext has just been superb in working side by side with us as a true partner. I would have no reservation in recommending Tim and Dext to any organization desiring equipment financing,” Vincent said.

Tim Vertz, Vice President for Dext Capital said, “We would like to congratulate the entire ION and Gamma West team in bringing this state-of-the-art cancer therapy device to patients in the Orem, UT, market. It’s a privilege to work with cancer therapy providers whose goal is to eradicate cancer via making investments in and providing the highest quality instrumentation on the market today.”

“We are thrilled to close a custom lease guidance facility for ION and Gammawest enabling the timely opening of this new facility to serve the medical needs of cancer patients in Orem, UT. As healthcare focused experts, our team continues to bring practical and transparent solutions to underserved medical providers and are thankful to the team at ION for allowing us to be a trusted finance partner,” said Kyin Lok, CEO of Dext Capital.